China STD diagnostics market is growing at a CAGR of around 9.5% during the forecast period. China, which is one of the largest developing countries across the globe, has been suffering from the wide-spread of STDs for a long time. Among all of the STDs in China, three are listed as the notifiable infectious diseases, i.e., Gonorrhoea, Syphilis, and HIV/AIDS, which demand more attention, which is influencing the growth of the China STD diagnostics market. Overall, the Yangtze River Delta region, the southwestern border area, and some other border regions are the places demanding more attention.
Visit for Global Sexually Transmitted Diseases (STD)
Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/sexually-transmitted-disease-market-size
The rate of STD in China has recently increased drastically over the years. In China, the high-risk community consists of migrants, workers, prostitutes and their clients, drug users, and homosexuals. Most of the STDs can be treated if it the disease is quickly diagnosed. In China, there are local specialized STD hospitals, including the Shanghai Skin Disease and other large and local hospitals such as Huashan hospital. These hospitals provide STD diagnosis tests across the region. Further, in 2016, the Chinese Centre for Disease Control and Prevention (CCDC) reported 96,000 new HIV cases in the first nine months. China has increased HIV testing efforts and changed its approach depending on the type of group or population being targeted.
In addition, Abbott Laboratories, Inc., AbbVie Inc., Becton, Dickinson and Co., Biocartis NV, Bio-Rad Laboratories, Inc., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd. among others are the key manufactures that encourages the China STD market growth. These market players are considerably contributing to the China STD diagnostic market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the China STD diagnostics market.
Research Methodology
The market study of the China STD Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. China STD Diagnostics Market by Disease Type
5.1.1. Chlamydia
5.1.2. Syphilis
5.1.3. Gonorrhea
5.1.4. Herpes Simplex Virus (HSV)
5.1.5. Human Papilloma Virus (HPV)
5.1.6. Human Immunodeficiency Virus (HIV)
5.1.7. Others
5.2. China STD Diagnostics Market by Product
5.2.1. Laboratory Testing Devices
5.2.2. Point-of-Care (POC) Testing Devices
5.3. China STD Diagnostics Market by End-user
5.3.1. Hospitals and Clinics
5.3.2. Diagnostic Centers
5.3.3. Homecare
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. AbbVie Inc.
6.3. Becton, Dickinson and Co.
6.4. Biocartis NV
6.5. Bio-Rad Laboratories, Inc.
6.6. Danaher Corp.
6.7. Eli Lilly and Co.
6.8. F. Hoffmann-La Roche Ltd.
6.9. Merck KGaA
6.10. Thermo Fisher Scientific, Inc.
1. CHINA STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2018-2025 ($ MILLION)
2. CHINA STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
3. CHINA STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
1. CHINA STD DIAGNOSTICS MARKET SHARE BY BIOMARKER DISEASE TYPE, 2018 VS 2025 (%)
2. CHINA STD DIAGNOSTICS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
3. CHINA STD DIAGNOSTICS MARKET SHARE BY END-USER, 2018 VS 2025 (%)